Aspirin use and bleeding events during thrombocytopenia after autologous stem-cell transplantation for multiple myeloma

BACKGROUND: In patients with cardiovascular (CV) comorbidities that necessitate antiplatelet therapy (APT), its optimal management during chemotherapy-induced thrombocytopenia remains elusive, as the risk of bleeding has to be balanced against the risk of CV events. The purpose of this study was to...

Descripción completa

Detalles Bibliográficos
Autores principales: Neuendorff, Nina Rosa, Boshikova, Boryana, Frankenstein, Lutz, Kirchner, Marietta, Rohde, Christian, Goldschmidt, Hartmut, Frey, Norbert, Müller-Tidow, Carsten, Jordan, Karin, Sauer, Sandra, Janssen, Maike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174307/
https://www.ncbi.nlm.nih.gov/pubmed/37182183
http://dx.doi.org/10.3389/fonc.2023.1168120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174307/
https://www.ncbi.nlm.nih.gov/pubmed/37182183
http://dx.doi.org/10.3389/fonc.2023.1168120

Ejemplares similares